Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Total 13F shares
-
6,787,129
-
Share change
-
+1,007,598
-
Total reported value
-
$33,117,000
-
Price per share
-
$4.88
-
Number of holders
-
23
-
Value change
-
+$4,918,998
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q2 2021
As of 30 Jun 2021,
aTYR PHARMA INC - COMMON STOCK (ATYR) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,787,129 shares.
The largest 10 holders included
FMR LLC, FEDERATED HERMES, INC., Alyeska Investment Group, L.P., VANGUARD GROUP INC, Ikarian Capital, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Telemetry Investments, L.L.C., RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA ADVISERS, LP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.